K2 HEALTH supplier risk profile Q1-2026: 159 shipments, 25 sources, China-focused medical device imports.
K2 HEALTH imported 159 shipments from 25 suppliers across 6 countries in Q1 2026, with China dominating at 57.9% of total volume. The company's sourcing is concentrated in Asia, with Thailand (15.7%) and Vietnam (12.6%) as secondary sources. Top suppliers include Mercator Medical Thailand and Shanghai Chengsheng T. All imports fall under HS Chapter 96 (miscellaneous manufactured articles).
Distance-screened against all 380 facilities in the ASPI Xinjiang Data Project. Proximity score: 100 / 100.
K2 HEALTH shows one sanctions watchlist name match. The company reports zero suppliers with known forced-labor exposure under UFLPA proximity screening.
25 distinct tier-1 suppliers in Q1 2026
| MERCATOR MEDICAL THAILAND | Thailand | 25 |
| SHANGHAI CHENGSHENG T | China | 20 |
| S S GLOVE | Vietnam | 17 |
| SHENZHEN LANTISE TECHNOLOGY LT | China | 16 |
| JINGXIN M | Malaysia | 15 |
| NINGBO SHIMAOTONG | China | 14 |
| CHANGZHOU CARE DE SANITARY MATERIAL | China | 13 |
| SPECIAL HEADWAY HK | China | 5 |
Share of Q1 2026 inbound shipments by source country
38 tier-2 + 36 tier-3 nodes mapped - sign up to see them.
Free Tarifflo account unlocks the complete tier 1 / 2 / 3 supplier graph, daily refresh, alerts, and sanctions + UFLPA monitoring on every shipment.